Countries › Brazil › Guide › 12. Sectors › Healthcare in Brazil: foreign capital in hospitals and health plans, ANS authorization and Anvisa drug registration
Healthcare in Brazil: foreign capital in hospitals and health plans, ANS authorization and Anvisa drug registration
Last verified: 2026-10-27 · Status: Stable
The Constitution bars foreign capital in healthcare unless a law allows it, and since 2015 the law allows foreign control of hospitals, clinics and family planning services, while health plan operators have been open to foreign shareholders since 2001. Health plan operators need an ANS operating authorization, sell under strict minimum coverage and renewal rules, and lose the authorization if they do not start selling within 180 days. Medicines and health products cannot be sold before Anvisa registration, decided within 120 days for priority and 365 days for ordinary drug applications.
Key facts
| Maximum Anvisa decision time, priority medicine registration | 120 daysLei nº 6.360 art. 17-A § 2 I, as of 2026-10-27 · in force |
|---|---|
| Maximum Anvisa decision time, ordinary medicine registration | 365 daysLei nº 6.360 art. 17-A § 2 II, as of 2026-10-27 · in force |
| Maximum validity of a product registration before renewal | 10 yearsLei nº 6.360 art. 12 § 1, as of 2026-10-27 · in force |
| Days for a new health plan operator to start selling before losing authorization | 180 daysLei nº 9.656 art. 8 § 2, as of 2026-10-27 · in force |
| Days of non payment in 12 months before an individual plan may be terminated | 60 daysLei nº 9.656 art. 13 sole paragraph II, as of 2026-10-27 · in force |
The rule
| Activity | Foreign capital | Rule |
|---|---|---|
| Hospitals, polyclinics, clinics | Allowed, including control | Lei nº 8.080 art. 23 II a |
| Family planning activities and research | Allowed, including control | Lei nº 8.080 art. 23 II b |
| Health plan operators | Allowed | Lei nº 9.656 art. 1 § 3 |
| Other healthcare activities | Only where a specific law allows | Constitution art. 199 § 3; Lei nº 8.080 art. 23 IV |
Where foreign capital may go in Brazilian healthcare.
Worked example
- A foreign hospital group buys control of a Brazilian hospital chain and its captive health plan: the hospitals fall under the 2015 opening (Lei nº 8.080 art. 23 II a), the plan operator under Lei nº 9.656 art. 1 § 3, and the operator must keep meeting its ANS authorization conditions (art. 8). A new drug the group imports needs Anvisa registration first; an ordinary application has a 365 day decision clock, a priority one 120 days (Lei nº 6.360 art. 17-A).
Step by step
- 1. Map each target activity against Lei nº 8.080 art. 23 and Lei nº 9.656 art. 1 § 3.
- 2. For a health plan operator, file the ANS authorization with services, network, staff and viability, and start selling within 180 days.
- 3. Register medicines and health products with Anvisa before any sale or import for consumption.
- 4. Calendar registration renewals for the first half of the last year of validity.
- 5. Check merger control filing duties for the acquisition.
Common traps
- Healthcare activities outside the cases listed in Lei nº 8.080 art. 23 remain under the constitutional ban unless another law opens them.
- A health plan operator that registers but does not sell within 180 days loses its authorization.
- Missing the renewal window makes the product registration lapse.
- Individual plans cannot be cancelled for default without the 60 day threshold and notice by the 50th day.
Sources
- Constitution of Brazil, Congress normas.leg.br
- Lei nº 8.080 (Health System Law), Congress normas.leg.br
- Lei nº 9.656 (health plans), Congress normas.leg.br
- Lei nº 6.360 (medicines and health products), Congress normas.leg.br
Related pages
- investing/foreign-investment-regime
- regulation/business-regulation-essentials
- finance/insurance-and-reinsurance
- trade/importing-and-exporting
- /calendar/
- /country/brazil/
- Live dashboard
Related: Brazil country profile · live dashboard · central bank and release calendar · our posts on X
